Polifarma announces the purchase of ISOCOLAN® brand and AIC codes
With this acquisition, Polifarma SPA intends to strengthen the list of products in gastroenterology, a sector in which it is already present.
Rome 25/06/2018 - Polifarma SPA announces the purchase of ISOCOLAN®'s AICs and product brand for Italy and the rest of the world from Società Giuliani SPA. The product will be distributed in Italy by Polifarma SPA as of today. With this acquisition, Polifarma SPA intends to strengthen the list of products in gastroenterology, a sector in which it is already present.
This acquisition, which follows the previous purchase of a product in the ophthalmology sector, proves the ownership's desire to consolidate the company's assets in the different areas in which the company operates.
ISOCOLAN® is a drug based on Macrogol 4000 associated with Sodium and Potassium salts, group C, which will be promoted in the gastroenterology sector, in the following formulations:
- 34.8 g Sachets
- 17.4 g Sachets
The ISOCOLAN® target market is evolving both in terms of units and values, with important companies operating in the sector.
The company, which basis are its organisation and its focus on innovation, intends to relaunch the product, backed by an investment plan that guarantees an evolution matching expectations in the short term.
Share
Are you a medical specialist?
Register on the site, take advantage
of the contents and services dedicated to you!
